Our news

MELD-ATG is halfway!

30. November 2022

MELD-ATG is thrilled to have reached half of the participants we need to include in the study. Successful clinical trials depend on the willingness of participants and dedication of the local teams. The MELD-ATG coordination team is sincerely thankful for the great efforts of all people involved and very excited to move forward with this promising study.